| Type | MGI:General | Description | several heterozygotes treated with DSS alone develop carcinomas by day 180 post-treatment, unlike DSS-treated wild-type controls some DSS-treated heterozygotes develop mucinous carcinoma with neoplastic glands invading the submucosa and penetrating the muscularis propria (T2 tumor stage), indicating an aggressive course |
